Debut Plus

₹1,213.5

▼ -63.73 -4.99%

10 Sept 2026

NSE Listed

ST-ASM · ASM 1
What does ST-ASM · ASM 1 mean?
BSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-08-13

Sudeep Pharma Limited (SUDEEPPHRM)

Volume: 2,83,504Avg Vol 1W: 2,49,080.4Avg Vol 1M: 2,29,245.0552W Range:₹524.05₹1,378
NSE BSE www.sudeeppharma.com AI Report
Key Ratios
Checked 3h ago
Market Cap₹13,706 Cr
Current Price₹1,213.5
Previous Close₹1,277.23
High / Low (52w)₹1,378 / ₹524.05
Volume2,83,504
Avg Vol (1W)2,49,080.4
Avg Vol (1M)2,29,245.05
Stock P/E75.05
Book Value₹78.21
Dividend Yield0%
ROE19.57%
ROA15.63%
Revenue (TTM)₹671 Cr
Revenue Growth9.3%
Profit Margin27.03%
Total Debt₹40 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹16.17
P/B15.52
Debt / Equity0.21
50 DMA₹1,010.74
200 DMA₹753.87
Day change-4.99%
SurveillanceST-ASM · ASM 1
Price Chart
₹1,213.5▲ 56.75% · 1Y
₹1344₹5304.0Cr
2025-11-28
2026-09-10

20-day avg volume: 2.3L shares

Pros
  • Healthy return on equity of 19.6%.
  • Company is almost debt-free.
Cons
  • Revenue fell 42% YoY.
  • Stock trades at a high P/E of 75.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹149 Cr₹116 Cr₹158 Cr₹125 Cr₹163 Cr₹172 Cr₹182 Cr₹158 Cr
EBITDA₹63 Cr₹39 Cr₹60 Cr₹46 Cr₹62 Cr₹63 Cr₹65 Cr₹56 Cr
Net Profit₹49 Cr₹29 Cr₹44 Cr₹31 Cr₹46 Cr₹47 Cr₹49 Cr₹41 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹511 Cr₹105 Cr₹80 Cr₹88 Cr₹90 Cr₹80 Cr₹671 Cr₹106 Cr
EBITDA₹189 Cr₹47 Cr₹35 Cr₹42 Cr₹37 Cr₹37 Cr₹236 Cr₹47 Cr
Net Profit₹139 Cr₹33 Cr₹25 Cr₹30 Cr₹27 Cr₹26 Cr₹173 Cr₹34 Cr
EPS12.79—————15.5—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹131 Cr₹213 Cr₹344 Cr₹420 Cr₹514 Cr₹717 Cr₹1,175 Cr
Total Liabilities₹50 Cr₹99 Cr₹180 Cr₹197 Cr₹158 Cr₹224 Cr₹277 Cr
Equity₹81 Cr₹114 Cr₹163 Cr₹223 Cr₹356 Cr₹493 Cr₹898 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹16 Cr₹46 Cr₹15 Cr₹71 Cr₹110 Cr₹89 Cr₹125 Cr
Investing₹-22 Cr₹-40 Cr₹-38 Cr₹-50 Cr₹-49 Cr₹-79 Cr₹-331 Cr
Financing₹12 Cr₹13 Cr₹51 Cr₹-10 Cr₹-13 Cr₹53 Cr₹247 Cr
Free Cash Flow₹16 Cr₹46 Cr₹15 Cr₹71 Cr₹110 Cr₹89 Cr₹125 Cr
Shareholding
Promoter 76.15% Institutions 17.46% Public 6.39%
Efficiency & Working Capital
ROCE22.2%
Interest Coverage27.8
Dividend Payout—
Debtor Days129 d
Inventory Days123 d
Payable Days39 d
Cash Conversion Cycle213 d
Working Capital Days252 d
Shareholding Details

As of 2026-06-30

Promoter76.2%
FII1.8%
DII15.6%
Institutions17.5%
Public6.4%
Promoter Pledge0%
No. of Shareholders35,695
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodJun 2025Nov 2025Nov 2025Dec 2025Mar 2026Jun 2026
Promoters91.1%76.2%76.2%76.2%76.2%76.2%
FIIs0%0.9%1.5%1.7%1.6%1.8%
DIIs0%14.8%14.8%17.6%18.1%15.6%
Public8.9%8.2%7.5%4.6%4.2%6.4%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders162,17,9822,17,98243,59936,50335,695
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Riva Resources Private LimitedShareholding of Promoter and Promoter Group40.4%4.56 Cr
Bhayani Sujit JaysukhShareholding of Promoter and Promoter Group21.2%2.39 Cr
Sujeet Jaysukh Bhayani HufShareholding of Promoter and Promoter Group5.7%64,60,747
Avani Sujeet BhayaniShareholding of Promoter and Promoter Group4.5%50,53,140
Shanil Sujit BhayaniShareholding of Promoter and Promoter Group4.5%50,25,000
Nuvama Crossover Opportunities Fund - Series IiiPublic Shareholding3%33,37,482
Nuvama Crossover Opportunities Fund - Series Iii A .Public Shareholding2.6%29,02,744
Nuvama Crossover Opportunities Fund - Series Iii B .Public Shareholding2.1%24,16,427
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap FundPublic Shareholding1.9%20,85,880
Mukul Mahavir AgrawalPublic Shareholding1.3%15,00,117
Sbi Healthcare Opportunities FundPublic Shareholding1.2%13,60,000
Jaysukh Jayantilal BhayaniShareholding of Promoter and Promoter Group0%0
Dipen Jaysukh BhayaniShareholding of Promoter and Promoter Group0%0
Urvir Jaysukh BhayaniShareholding of Promoter and Promoter Group0%0
Rhea Sujit BhayaniShareholding of Promoter and Promoter Group0%0
Anjana Rajendrabhai PatelShareholding of Promoter and Promoter Group0%0
Rajendra Chunilal PatelShareholding of Promoter and Promoter Group0%0
Vidhi Shanil BhayaniShareholding of Promoter and Promoter Group0%0
Inaraa Shanil BhayaniShareholding of Promoter and Promoter Group0%0
Alka Pravinchandra KotakShareholding of Promoter and Promoter Group0%0
Pravinchandra Talakshibhai KotakShareholding of Promoter and Promoter Group0%0
Harsh Pravinbhai KotakShareholding of Promoter and Promoter Group0%0
Dipen Jaysukh Bhayani HufShareholding of Promoter and Promoter Group0%0
Urvir Jaysukh Bhayani HufShareholding of Promoter and Promoter Group0%0
Pravinbhai Talkshibhai Thakkar HufShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sujit J BhayaniChairman / Executive Director / Managing Director2026
Shanil Sujit BhayaniE D & Wholetime Director2026
Ajay Shrirang KandelkarE D & Wholetime Director2026
Milin MehtaNon-Exec & Non-Independent Dir2026
S. RaghunandanIndependent Non Exe. Director2026
Samaresh PandaIndependent Non Exe. Director2026
Reshma PatelIndependent Non Exe. Director2026
Sujit GulatiIndependent Non Exe. Director2026
Dimple Ashwinbhai MehtaCompany Sec. & Compli. Officer2026
Segments — Geography
RegionRevenueShare
India₹153 Cr43%
USA₹55 Cr15.4%
Others₹148 Cr41.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1121111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-04Board Meetings—
forthcoming2026-07-23Dividend (1.5/- per share)Final
dividend2026-07-23₹1.5 (150%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202667600339718
20263080000308
2026160033857
Company Information
Incorporated1989
ChairmanSujit J Bhayani
AuditorB S R & Co
Investor Email[email protected]
🌐 www.sudeeppharma.com ↗

📍 129/1/A GIDC Estate Nandesari, Vadodara, Gujarat, 391340

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Styrenix Performance Materials Ltd.Suba Hotels LimitedSubex Ltd.Subros LimitedSudarshan Colorants India Ltd.Sudarshan Chemical Industries Ltd.Sukhjit Starch & Chemicals Ltd.Sula Vineyards LimitedSumax Engineering LimitedSumedha Fiscal Services LimitedSumeet Industries Ltd.Sumeet Industries Ltd.All “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search